Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of ION464 in adults with Multiple System Atrophy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• ION464

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Multiple System Atrophy | Phase 1 | Status: RECRUITING